AbbVie registers Phase 1 PK study of trosunilimab given IV and SC in healthy adultsNov 13Weekly roundup, 8 itemsABBV-295ABBV-722
AbbVie posts updates on three early-stage trials: obesity, drug interaction, glabellar linesNov 6Weekly roundup, 5 itemsABBV-295AbbVieUpdated
AbbVie registers three new trials spanning obesity, head and neck cancer, and atopic dermatitisAug 7Weekly roundup, 3 itemsABBV-295AbbVie